Axicabtagene Ciloleucel Infusion Cells/kg patient Suppliers & Bulk Manufacturers
Available Forms: IV Infusion
Available Strengths: Cells/kg patient
Reference Brands: Yescarta (US & EU)
Category: Cell & Gene Therapies
Axicabtagene ciloleucel is a CAR T-cell therapy that reprograms a patient’s T cells to target CD19-positive cancer cells. It provides rapid, targeted destruction of lymphoma cells, offering durable remissions, improved survival, and quality of life for patients with relapsed or refractory large B-cell lymphoma when administered in specialized centers.
Product Description:
Axicabtagene ciloleucel (Yescarta) is regulated in the EU and US, supported by dossiers demonstrating safety, efficacy, and manufacturing quality compliant with GMP and MDR standards. In the US, FDA approval involves extensive clinical validation and safety assessments. In the EU, CE marking certifies conformity with MDR regulations. These CAR T-cell therapies undergo validation, stability testing, and audits, with detailed documentation including clinical trial data, safety profiles, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to innovative, life-saving immunotherapies supporting advanced cancer treatments worldwide.
Axicabtagene Ciloleucel Infusion — third party manufacturing & bulk supply
Axicabtagene Ciloleucel Infusion Cells/kg patient is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Axicabtagene Ciloleucel Infusion is supplied as IV Infusion — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Axicabtagene Ciloleucel Infusion listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Axicabtagene Ciloleucel Infusion →Frequently Asked Questions
Axicabtagene Ciloleucel is used for the treatment of certain types of large B-cell lymphomas that have not responded to previous therapies or have relapsed after at least two lines of systemic treatment. It is a type of CAR T-cell therapy, where a patient’s own T cells are genetically modified to recognize and destroy cancer cells. This treatment offers a potentially curative option for patients with aggressive, treatment-resistant lymphomas.
Axicabtagene Ciloleucel is made from a patient’s own white blood cells (autologous T cells) that are collected and genetically engineered to express a chimeric antigen receptor (CAR) targeting the CD19 antigen found on B-cell malignancies. The modified cells are then multiplied and infused back into the patient to attack and kill the cancer cells.
The trade name of Axicabtagene Ciloleucel is Yescarta®.
The brand name of Axicabtagene Ciloleucel is Yescarta.
Related Products
Tisagenlecleucel Infusion
Strength:
cells/kg patient
Form: IV Infusion
Reference Brands: Kymriah(US & EU)
View Details
Lisocabtagene Maraleucel Infusion
Strength:
Approved for relapsed/refractory large B-cell lymphoma, with a standard dose of 100 million CAR T cells per infusion
Form: IV Infusion
Reference Brands: Breyanzi (US & EU)
View Details
Idecabtagene Vicleucel Infusion
Strength:
Approved for relapsed/refractory multiple myeloma, with dosing based on patient weight, delivering a personalized, targeted therapy to eliminate cancer cells
Form: IV Infusion
Reference Brands: Abecma(US & EU)
View Details
Onasemnogene Abeparvovec Injectable
Strength:
Single-dose IV infusion providing 6 x 10^13 vector genomes (vg) per patient
Form: Injectable gene therapy
Reference Brands: Zolgensma(US & EU)
View Details
Etranacogene Dezaparvovec. Infusion
Strength:
Cells/kg patient
Form: Intravenous infusion
Reference Brands: Hemgenix (US & EU)
View Details
Darleukin Injection
Strength:
A standardized dose of 120 million adipose-derived stem cells per injection
Form: Intralesional injection
Reference Brands: Alofisel(US & EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
